SCHEMBL2482056

SCHEMBL2482056

Cc1cc(OC(=O)c2ccccc2)c(OC(=O)c2ccccc2)c(-c2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.45
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
BACE1 P56817 1/20 0.44
SLC6A3 Q01959 1/20 0.44
MEN1 O00255 2/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
MDM2 Q00987 1/20 0.43
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
EGFR P00533 1/20 0.40
TOP1 P11387 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2508951 0.85 MAPT (0.47) KMT2AMAPTSMN1; SMN2BACE1SLC6A3
SCHEMBL2482229 0.83 MAPT (0.50) KMT2AMAPTSMN1; SMN2SLC6A3MEN1
SCHEMBL2482165 0.83 KMT2A (0.46) KMT2AMAPTSMN1; SMN2BACE1SLC6A3
SCHEMBL2483526 0.82 MAPT (0.51) KMT2AMAPTSMN1; SMN2BACE1SLC6A3
SCHEMBL2882737 0.82 KMT2A (0.42) KMT2AMAPTSMN1; SMN2BACE1SLC6A3
SCHEMBL2478197 0.81 MAPT (0.44) KMT2AMAPTSMN1; SMN2SLC6A3MEN1
Benzamide SCHEMBL21771939 0.81 PARP10 (0.49) KMT2AMAPTBACE1MEN1PTGDR2
SCHEMBL2482478 0.80 KMT2A (0.43) KMT2AMAPTSMN1; SMN2BACE1SLC6A3
SCHEMBL2505165 0.79 KMT2A (0.45) KMT2AMAPTSMN1; SMN2SLC6A3MEN1
SCHEMBL2481446 0.79 KMT2A (0.43) KMT2AMAPTSMN1; SMN2BACE1SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT KMT2A 1611/4885MAPT 2384/4885SMN1; SMN2 4422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.